| Source:
Use of injectable contraceptives has risen dramatically. Worldwide between 1995 and 2005, the number of married women using injectables nearly tripled-from about 12 million to over 32 million. By 2015 use is projected to reach nearly 40 million. Today, injectables are among the most popular methods in many countries, including Haiti, Indonesia, Kenya, Malawi, and South Africa. Women choose injectables because they are highly effective, long acting, reversible, and private. Many women do not choose them or stop using them, however, because of side effects-changes to regular bleeding patterns or weight gain-or because they have trouble returning to the clinic for repeat injections. To meet rising demand and to help clients use injectables effectively, family planning programs can develop a strategy to deliver expanded good-quality injectables services. (excerpt)
- Regions/Countries:
- Global |
- Global
WHO Upholds Guidance: Women With or at Risk of HIV Can Safely Use Hormonal Methods
WHO released a statement on February 16, 2012, upholding guidance indicating that women with HIV or at high risk of HIV can safely use hormonal contraceptives, including injectables, to prevent pregnancy. However, WHO is instructing health care providers to strongly advise such women who decide to use progestin-only injectables to also always use male or female condoms for protection against HIV. Read more about WHO's statement.
The information provided on this website is not official U.S. Government information and does not represent the views or position
of the U.S. Agency for International Development, the U.S. Government, or The Johns Hopkins University. Read our full Security & Privacy Policies.